Continuum Advisory LLC Reduces Stock Position in The Procter & Gamble Company (NYSE:PG)

Continuum Advisory LLC decreased its position in shares of The Procter & Gamble Company (NYSE:PG) by 3.1% in the third quarter, HoldingsChannel reports. The firm owned 9,172 shares of the company’s stock after selling 296 shares during the quarter. Continuum Advisory LLC’s holdings in Procter & Gamble were worth $1,532,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of PG. Itau Unibanco Holding S.A. purchased a new position in shares of Procter & Gamble during the second quarter worth $28,000. Fairway Wealth LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at about $29,000. RPg Family Wealth Advisory LLC acquired a new position in shares of Procter & Gamble in the 3rd quarter valued at about $33,000. POM Investment Strategies LLC acquired a new stake in Procter & Gamble during the second quarter worth about $34,000. Finally, Quest Partners LLC purchased a new position in Procter & Gamble during the second quarter valued at approximately $36,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Down 1.3 %

Shares of PG opened at $173.82 on Monday. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The firm has a 50-day moving average price of $170.76 and a 200 day moving average price of $169.40. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $180.43. The firm has a market capitalization of $409.35 billion, a P/E ratio of 29.97, a P/E/G ratio of 3.75 and a beta of 0.44.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business’s revenue for the quarter was down .6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.83 EPS. Sell-side analysts forecast that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s payout ratio is 69.48%.

Insider Buying and Selling at Procter & Gamble

In related news, CEO Gary A. Coombe sold 47,847 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the sale, the chief executive officer now owns 39,977 shares in the company, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total value of $2,210,944.00. Following the transaction, the insider now owns 11,595 shares in the company, valued at $2,002,804.35. This trade represents a 52.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 83,080 shares of company stock valued at $14,629,038 over the last 90 days. 0.18% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the stock. DA Davidson raised shares of Procter & Gamble from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $160.00 to $209.00 in a research note on Monday, November 25th. Piper Sandler started coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target on the stock. Barclays downgraded shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective for the company. in a research report on Monday, September 30th. Royal Bank of Canada restated a “sector perform” rating and issued a $164.00 price target on shares of Procter & Gamble in a research note on Monday, October 21st. Finally, JPMorgan Chase & Co. boosted their price objective on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Eight equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $180.45.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.